Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Enregistré dans:
| Format: | Online |
|---|---|
| Langue: | anglais |
| Publié: |
IntechOpen
2021
|
| Sujets: | |
| Accès en ligne: | ONIX_20210420_9781789848090_2372 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|